(redirected from escitalopram oxalate)
Also found in: Medical.


A drug of the SSRI class, C22H21FN2O, that is a stereoisomer of citalopram and is given in the form of its oxalate to treat depression and anxiety.

[es-, isomer pref. (pronunciation spelling of the first letter of S-stereoisomer, isomer with counterclockwise rotation, from Latin sinister, left-handed; see sinister) + citalopram.]


n escitalopram m
Mentioned in ?
References in periodicals archive ?
announces today a Phase 3 trial for Major Depressive Disorder (MDD) that will compare Soterix Medical's Transcranial Direct Current Stimulation (tDCS) - Limited Total Energy (LTE) technology against a fully dosed, effective antidepressant Escitalopram oxalate (Lexapro).
The Food and Drug Administration has approved escitalopram oxalate for the treatment of generalized anxiety disorder.
Amneal Pharmaceuticals, LLC today announced the launch of Escitalopram Oxalate Oral Solution in 5 mg/5 mL strength, the first generic in liquid form on the market.
Food and Drug Administration's Orange Book for Forest's LEXAPRO(R) brand escitalopram oxalate tablet products.
In this study, patients who met DSM-IV([R]1) criteria for both insomnia and GAD were randomized to receive nightly LEXAPRO([R])brand escitalopram oxalate 10 mg, which is approved for the treatment of GAD, and either LUNESTA 3 mg (n=294) or placebo (n=301) for the first eight weeks, followed by a two-week period in which patients discontinued study drug but continued receiving escitalopram and placebo.
Completed pilot product development for a thin film formulation of escitalopram oxalate, a selective serotonin reuptake inhibitor (SSRI) marketed under the brand name Lexapro(R) for the treatment of depression and generalized anxiety disorder.
Teva's AB-rated Escitalopram Oxalate Tablets are indicated for the treatment of depression.
Escitalopram oxalate is indicated for depression and generalized anxiety disorders and is marketed under the brand name Lexapro(R).